The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

The decision comes only a week after it approved a new round of messenger RNA shots from Pfizer and Moderna, which both ...

Friday, the FDA granted Emergency Use Authorization to Novavax Inc.’s (NASDAQ:NVAX) COVID-19 Vaccine, Adjuvanted (2024-2025 ...

The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID-19 ...

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...

The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the ...

Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a ...

The Food and Drug Administration granted emergency use authorization Friday for an updated version of the Novavax COVID-19 ...

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and ...

The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID ...